21 participants
A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-09-05
- Start Date:
- 2013-10-31
- Completion:
- 2019-03-31
Conditions
- Multiple Myeloma in Relapse
Interventions
- DRUG
No Results Yet